EATG » News

1st Interim Meeting for ESTICOM

EATG participated in the 1st Interim Meeting of the ESTICOM project (http://www.esticom.eu) in Brussels on 17-18/7. ESTICOM is, to some extent, the continuation and revision of the much-used and very useful…

EATG Project Management and Evaluation Webinars – All you need

EATG organised a series of webinars on the management, evaluation and monitoring of projects in advocacy. Hosted and presented by EATG member and social science researcher Ian Hodgson, the webinars…

Apply now! STEPS – Cure Workshop at the EACS Conference in Milan

If you are planning to attend the EACS meeting in Milan, Italy (October 25-27, 2017), you are invited to apply to attend the fourth community meeting on HIV cure, therapeutic…

Call for applications: European HIV Academy for Enabling Legal Environments

European HIV Academy for Enabling Legal Environments 13-14 September 2017 Venue: Deutsche AIDS Hilfe (DAH), Berlin, Germany Apply here: https://www.surveymonkey.com/r/WZRFV35 Applications will close on 26 July 2017 (23:59 CET)  …

Webinar: IP barriers to affordable quality medicines

EATG will host a community oriented webinar on intellectual property (IP) barriers to affordable quality medicines and ways in which these can be addressed on 12 July from 12:00 to…

EATG is concerned by the Cochrane review of DAA treatment against HCV infection

Direct acting agents used against hepatitis C infection are clinically effective and reliable. EATG, the pan-European network of communities of people living with and affected by hepatitis C (HCV) and…

EATG joins new coalition calling on EU to take action to eliminate viral hepatitis by 2030

Launched at an event in the European Parliament on 7 June 2017, the ACHIEVE (short for Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe) coalition calls…

EATG Tuberculosis Team met Belgian Senate

  On May 15, EATG and TBpeople, EECA network of people with tuberculosis with support from the Stop TB Partnership, convened a meeting at the Belgian Senate to raise political awareness to…

EUPATI webinar: Guidance for patient involvement in ethical review of clinical trials

EUPATI will host a webinar, Guidance for patient involvement in ethical review of clinical trials on 29 May 2017 from 17:00 to 18:30 CET. For more information about the webinar and how…

HepHIV 2017 Conference call to action and proceedings

The HepHIV 2017 Conference: HIV and Viral Hepatitis: Challenges of Timely Testing and Care was held by HIV in Europe, in collaboration with European stakeholders, from 31 January - 2…

EmERGE newsletter, May 2017

EmERGE is a project funded by the European Union’s Horizon 2020 Research and Innovation Programme. EmERGE will develop a mHealth platform to enable self-management of HIV in patients with stable disease.…

Stephan Dressler’s presentation on hepatitis B treatment

EATG held an interesting and successful ECAB meeting on viral hepatitis treatment and research in Tbilisi, Georgia in December 2016. The report on the meeting was published previously. This presentation…

ECDC Malta Conference Report Now Out

ECDC has announced on 04/05/2017 the finalisation and  and publication of the notes of the important Malta Presidency HIV Conference (Fast-tracking the end of AIDS in Europe – practical evidence-based interventions) held…

CoPE – Special Round of Applications! Apply Now!

We are pleased to announce a special call for CoPE applications, addressing the specific needs of migrant communities in the European and Central Asian region. This call supports the translation…

Hepatitis C Civil Society Declaration launched

At the Hepatitis C Community Summit held on 18-19 April 2017 in Amsterdam, civil society and community organisations from all over Europe launched a declaration to address the urgent need…

EATG is hiring! Executive Assistant position

EATG is looking for an Executive Assistant (EA). The EA will assist the Executive Director and lead the EATG team in its administrative functions. S/he will organize and supervise the…

Do you want to become an EATG intern?

EATG is looking for an intern to support our project based work and office related work. The intern will assist other staff members in their work, but will also get…

Open letter to Gilead Sciences about PrEP by EATG and PrEP in Europe Initiative

Please read and share the letter signed by EATG, as Europe’s transnational HIV treatment and prevention advocacy group, and the PrEP in Europe Initiative (PEI), a partnership of European prevention and…

Ageing with HIV conference follow-up webinar online

The recording from the Ageing with HIV webinar held on 30 March 2017 is now available online:https://www.ageingwithhiv.com/webinars. The webinar is presented by four young persons who attended the Phase 2 conference ‘New…

Interview with Andrej Senih at the Policy Working Group meeting

In this interview, EATG Policy Working Group chair Andrej Senih discusses the topics and outcomes of the meeting the PWG had on 17-18 March 2017. He also explains the significance…

Fresh approach to TB vaccine offers better protection

New vaccine completely protected 41 percent of nonhuman primates; standard vaccine protected none A unique platform that resulted in a promising HIV vaccine has also led to a new, highly…

We found ways to shorten the turnaround time for diagnosing babies with HIV

They say timing is everything. And in sub-Saharan Africa, where roughly a third of untreated HIV infected babies die before they reach the age of one, a timely diagnosis is…

Global summit on IP and access discusses impact of TRIPS-Plus measures on public health

A network of civil society organisations chose the birthplace of the World Trade Organization, Marrakesh, to hold a global summit on intellectual property and access to medicines this week. Part…

WHO position statement on the use of delamanid for MDR-TB

15 January 2018 | Geneva: The World Health Organization (WHO) Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB), following…

TB Europe Coalition releases two new publications

TB Europe Coalition released two new publications - an information brochure about the forthcoming United Nations High-Level Meeting on TB to be held in September this year, and a set…

HIV i-Base: HIV Treatment Bulletin, 5 January 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. The publication starts 2018 with a new look: Shorter… faster… more often… More information here. The online version…

Factors associated with access to HIV testing and primary care among migrants living in Europe: cross-sectional survey

ABSTRACT Background There is a heavy and disproportionate burden of human immunodeficiency virus (HIV) infection among migrant communities living in Europe. Despite this, the published evidence related to HIV testing,…

Hepatitis C treatment highly effective in harder-to-treat HIV coinfected patients, Spanish real-life study shows

Hepatitis C virus (HCV) treatment using direct-acting agents (DAAs) is highly effective and safe in harder-to-treat HIV co-infected patients, Spanish researchers report in AIDS. A sustained virological response (SVR), or…

Hematopoietic stem cell transplantation safe in patients with HIV

An analysis of hematopoietic stem cell transplant recipients in the United States over a 14-year period showed that patients with HIV do not have an increased risk for serious in-hospital…

Investigation questions transparency for failed TB vaccine

The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials. Oxford University scientists developing the MVA85A vaccine, intended…

Ukraine to finance expanded opioid substitution therapy programme

The Government of Ukraine has committed to fund and expand access to opioid substitution therapy (OST) for over 10 000 patients at 178 health-care facilities in 2018. This represents a…

War in Ukraine has escalated HIV spread in the country

Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to…

Johns Hopkins is the first center in the U.S. to be approved for living donor HIV-positive to HIV-positive kidney transplants

Living kidney donors are currently being evaluated for this medical milestone Approximately 122,000 people are on the transplant waiting list in the U.S. at any one time. Allowing HIV-positive living…

HIV does not increase aging-related brain changes in patients on ART

Researchers said they found no evidence that HIV accelerates aging-related brain changes over a 2-year period in middle-aged patients on successful ART. “This provides reassurance that, with virological suppression, [people…

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

Low-level HIV viral load, above the limit of detection, is an important warning signal for future treatment failure and World Health Organization guidelines on spotting treatment failure need to be…

Mother-to-child HIV transmission higher when mother has other STIs

A new study confirms that HIV-infected pregnant women have a higher risk of transmitting the HIV to their infants if the mothers also have another sexually transmitted infection. The research…

One-time routine HIV screening at age 25 optimal with no risk factors

For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective, according to a study published in the Journal…

Positive LAM results predict mortality in children with HIV

Children with HIV in Kenya whose urine samples tested positive for lipoarabinomannan, or LAM — a biomarker of tuberculosis — had a nearly fivefold increased risk for mortality compared with…

Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

Two new qualitative studies from Toronto shed light on how stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience of taking it. In the first, young gay men…

Hepatitis A vaccines effective in high-risk populations during outbreak

Two-dose hepatitis A vaccination was an effective preventive measure among HIV-positive individuals, including a high study population of men who have sex with men, during an ongoing outbreak of acute…